The weekly litigation news digest is live. Subscribe now

IP Verse

Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation Thereof - EP2682388

The patent EP2682388 was granted to Mylan Laboratories on Jan 10, 2018. The application was filed on Jun 22, 2009 under application number EP13003519A. The patent is currently recorded with a legal status of "Revoked".

EP2682388

MYLAN LABORATORIES
Application Number
EP13003519A
Filing Date
Jun 22, 2009
Status
Revoked
Apr 3, 2020
Publication Date
Jan 10, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HOEFER & PARTNER PATENTANWALTE MBBOct 10, 2018HOEFER & PARTNER PATENTANWALTE MBB -
LES LABORATOIRES SERVIEROct 10, 2018- -

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0496588
DESCRIPTIONUS4508729
DESCRIPTIONUS4914214
DESCRIPTIONUS6696481
DESCRIPTIONWO2007099216
DESCRIPTIONWO2007099217
OPPOSITIONEP1354873
OPPOSITIONEP2161257
OPPOSITIONEP2318365
OPPOSITIONWO2007099216
OPPOSITIONWO2007099217
OPPOSITIONWO2009157018
SEARCHWO2007099216
SEARCHWO2007099217

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents